(1-(3-(9H-carbazol-4-yloxy)-2-hydroxypropyl)piperidin-4-yl)(phenyl)methanone

ID: ALA1082827

PubChem CID: 46889852

Max Phase: Preclinical

Molecular Formula: C27H28N2O3

Molecular Weight: 428.53

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(c1ccccc1)C1CCN(CC(O)COc2cccc3[nH]c4ccccc4c23)CC1

Standard InChI:  InChI=1S/C27H28N2O3/c30-21(17-29-15-13-20(14-16-29)27(31)19-7-2-1-3-8-19)18-32-25-12-6-11-24-26(25)22-9-4-5-10-23(22)28-24/h1-12,20-21,28,30H,13-18H2

Standard InChI Key:  ZWXYSVRFDSVYEU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   10.7737  -25.4403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4897  -25.0272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4869  -24.1970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1995  -23.7820    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.9151  -24.1916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6277  -23.7767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3433  -24.1863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6246  -22.9521    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.0560  -23.7713    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7714  -24.1840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4819  -23.7726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4831  -22.9476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7675  -22.5358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0509  -22.9490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1972  -22.5353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0592  -25.0276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0521  -24.1980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7678  -23.7856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4388  -23.6448    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7753  -22.8906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5936  -22.9775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0762  -22.3134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7417  -21.5617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9198  -21.4784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4408  -22.1436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9113  -22.9476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9093  -23.7728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6227  -24.1850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3377  -23.7727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3351  -22.9439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6213  -22.5353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1972  -21.7108    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 12 15  1  0
 16 17  2  0
  6  7  1  0
 17 18  1  0
  3 18  2  0
  6  8  1  0
 18 21  1  0
 20 19  1  0
 19 17  1  0
  7  9  1  0
  9 10  1  0
 20 21  2  0
  3  4  1  0
 21 22  1  0
  1  2  2  0
 22 23  2  0
  4  5  1  0
 23 24  1  0
 16  1  1  0
 24 25  2  0
 25 20  1  0
  5  6  1  0
 15 26  1  0
  9 14  1  0
 26 27  2  0
 10 11  1  0
 27 28  1  0
 11 12  1  0
 28 29  2  0
 12 13  1  0
 29 30  1  0
 13 14  1  0
 30 31  2  0
 31 26  1  0
  2  3  1  0
 15 32  2  0
M  END

Associated Targets(Human)

ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB3 Tclin Beta-3 adrenergic receptor (5850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 428.53Molecular Weight (Monoisotopic): 428.2100AlogP: 4.66#Rotatable Bonds: 7
Polar Surface Area: 65.56Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.90CX LogP: 4.15CX LogD: 3.53
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.42Np Likeness Score: -0.53

References

1. Tasler S, Baumgartner R, Aschenbrenner A, Ammendola A, Wolf K, Wieber T, Schachtner J, Blisse M, Quotschalla U, Ney P..  (2010)  A vHTS approach for the identification of beta-adrenoceptor ligands.,  20  (11): [PMID:20434333] [10.1016/j.bmcl.2010.04.009]

Source